Flora Growth Corp. - stock earnings
FLGC Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | 1.2 million USD | 17.3 million USD |
| 2023Q2 | -44.6 million USD | 21.5 million USD |
| 2023Q1 | -3.9 million USD | 20.1 million USD |
| 2022Q4 | -12.5 million USD | 11.5 million USD |
| 2022Q3 | -7.4 million USD | 10.8 million USD |
| 2022Q2 | -43.1 million USD | 10.0 million USD |
| 2022Q1 | -12.5 million USD | 4.8 million USD |
| 2021Q4 | -12.5 million USD | 4.8 million USD |
| 2021Q3 | -3.6 million USD | 2.1 million USD |
| 2021Q2 | -3.0 million USD | 1.2 million USD |
| 2021Q1 | -2.5 million USD | 1.1 million USD |
| 2020Q4 | -5.8 million USD | 53000 USD |
| 2020Q3 | -5.8 million USD | 53000 USD |
| 2020Q2 | -1.7 million USD | ? USD |
| 2019Q2 | -1.9 million USD | ? USD |
FLGC Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -59.8 million USD | 72.4 million USD |
| 2022 | -52.6 million USD | 37.2 million USD |
| 2021 | -21.4 million USD | 9.0 million USD |
| 2020 | -14.3 million USD | 106000 USD |
| 2019 | -2.8 million USD | ? USD |
FLGC
Price: $1.64
52 week price:
Earnings Per Share: -6.34 USD
P/E Ratio: -0.09
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 2.7 million
Market Capitalization: 21.4 million